Study 23119
Healthy Ages 18-35 - Earn up to $1,900
If you've previously submitted an application, call 417-831-2048 to enroll. Or submit your application now.
Participant Requirements: Women, ages 18-35, non-nicotine users for 60 days.. Females must be willing to practice abstinence or use adequate contraception from 7 days before dosing until 30 days post final patch removal, such as barrier methods containing or used with spermicidal agent (e.g., diaphragm with spermicide or condom with spermicide), surgical sterilization (e.g. bilateral oophorectomy for at least 6 months or total hysterectomy for at least 3 months) or bilateral tubal ligation at least 6 months prior. BMI (Body Mass Index) must be between less than 30.
What: This will be a clinical research study to assess the skin irritation and sensitization of an investigational birth control patch vs a marketed patch. The patch will be placed on upper back.
When: This study will consist of 9 outpatient visits and a telephone call. . Study dates are as follows:
Group 7
Visit DatesHow Much: $1,900
Group 8
Visit DatesHow Much: $1,900
Group 9
Visit DatesHow Much: $1,900
Group 10
Visit DatesHow Much: $1,900
Group 11
Visit DatesHow Much: $1,900
Physical: Friday, April 16, 2021 Thursday, April 29, 2021 Monday, May 17, 2021
All study dates are tentative and subject to change.
We will update the study list every Wednesday. Be sure to check with us either by calling or by looking online. Call (417) 831-2048 or come by 1820 West Mt. Vernon for more information. Office hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
Due to the COVID-19 Pandemic, you are now able to sign up for this particular study by clicking the "Sign-Up Button" below and a QPS Recruiting Coordinator will contact you directly.
If you haven’t already, please fill out an application and a QPS Recruiting Coordinator will contact you
Referral Program
Don't forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.*
*No referral bonuses are paid out for outpatient vaccine studies.
